| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.21 | 0.002 |